Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | YMAB | AZN | AMGN | GILD | GSK |
| Company | Y-Mabs Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 8.59 | 208.75 | 377.91 | 152.34 | 60.93 |
| High | 8.61 | 208.95 | 379.93 | 152.82 | 61.06 |
| Low | 8.59 | 205.81 | 374.13 | 150.33 | 59.98 |
| Latest | 8.61 | 207.12 | 377.00 | 151.46 | 60.22 |
| Change | +0.02 | -1.55 | -2.73 | -1.28 | -0.96 |
| % Change | +0.23% | -0.74% | -0.72% | -0.84% | -1.57% |
| Volume | 760,600 | 954,413 | 600,946 | 2,309,061 | 2,371,745 |
| 20-Day Average Volume | 874,510 | 2,925,720 | 2,928,554 | 8,232,781 | 6,472,592 |
| Previous Close | 8.59 | 208.67 | 379.73 | 152.74 | 61.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.56 | 193.43 | 359.70 | 146.11 | 55.49 |
| 20-Day Raw Stochastic | 100.00% | 84.80% | 82.77% | 79.43% | 88.80% |
| 20-Day Relative Strength | 77.65 | 65.78 | 63.55 | 64.04 | 71.29 |
| Weighted Alpha | -45.79 | +49.75 | +33.48 | +48.09 | +76.62 |
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 56% Buy | 64% Buy | 80% Buy | 72% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.23% since 09/08/25 | +1.48% since 02/11/26 | +2.85% since 02/11/26 | -2.78% since 02/11/26 | +2.87% since 02/11/26 |
| Low | 8.57 on 09/11/25 | 202.10 on 02/12/26 | 361.71 on 02/13/26 | 150.33 on 02/19/26 | 58.05 on 02/12/26 |
| High | 8.61 on 09/15/25 | 212.71 on 02/18/26 | 380.58 on 02/18/26 | 156.95 on 02/13/26 | 61.69 on 02/18/26 |
| 1-Month | |||||
| %Chg | +1.06% since 08/15/25 | +10.07% since 01/16/26 | +14.11% since 01/16/26 | +21.26% since 01/16/26 | +24.78% since 01/16/26 |
| Low | 8.51 on 08/18/25 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.28 on 01/20/26 | 47.62 on 01/20/26 |
| High | 8.61 on 09/15/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 3-Month | |||||
| %Chg | +82.80% since 06/13/25 | +16.75% since 11/19/25 | +10.11% since 11/19/25 | +18.27% since 11/19/25 | +29.84% since 11/19/25 |
| Low | 3.90 on 06/20/25 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.81 on 11/20/25 |
| High | 8.61 on 09/15/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | +84.37% since 03/14/25 | +30.62% since 08/19/25 | +27.56% since 08/19/25 | +28.39% since 08/19/25 | +51.87% since 08/19/25 |
| Low | 3.55 on 05/15/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 38.63 on 09/02/25 |
| High | 8.61 on 09/15/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 391,221 | 323,627,968 | 204,700,304 | 189,501,472 | 124,709,680 |
| Shares Outstanding, K | 45,438 | 1,550,908 | 539,068 | 1,240,680 | 2,038,406 |
| Annual Sales | 87,690,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -29,670,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 19,530,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,464,090,000 |
| Last Quarter Net Income | -3,240,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 846,040,000 |
| 60-Month Beta | 0.53 | 0.34 | 0.46 | 0.36 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 08/08/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.26 on 02/04/26 |
| Latest Earnings Date | 11/14/25 | 05/05/26 | 05/07/26 | 04/23/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.478 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.86 | 17.09 | 19.05 | 13.47 |